Hosted by Tobin Arthur
DenTriage is a comprehensive mobile and web-based platform that will provide a convenient way for patients to receive timely guidance and care for urgent and non-urgent dental issues using Tele-Dentistry. DenTriage enables consumers to have urgent questions answered, obtain a[...]
Clint McGill is addressing one of the biggest challenge in youth sports - building mental toughness. As a former high level baseball player himself, Clint was like many parents involved with their kid's sports activities...but he decided to apply well[...]
Neobe Therapeutics is an early-stage startup engineering safe recombinant bacterial products to enable immune infiltration in solid tumors. Their bacterial products combine innate tumor colonization with genetically engineered inducible biosensors to disrupt tumor microenvironment barriers to infiltration. By enabling successful[...]
In a wide ranging discussion, with Lazurite Co-Founder/CEO Eugene Malinskiy, we learn more about the origins of the company, it's current status, and get a glimpse into where its headed.
For Lazurite’s inaugural device, the necessity of safety served as the[...]
Mr. Barletta is the founder of an advisory firm based in Washington DC called Jones Point. The firm possesses a unique combination of more than two decades of experience in Washington and deep Wall Street relationships. This differentiator allows Jones[...]
DelNova, Inc. is a biopharmaceutical company focused on addressing unmet medical needs. DelNova is resolving complications arising from botulinum toxin therapies (eg. Botox®). The first product under development, ReViVox™ is based on a clinically validated drug currently approved for a[...]
ParaNano Wound Care (PWC) solves a global problem in treatment of infection in chronic wounds: detection, notification, and early intervention. Infection in chronic wounds currently drives $27 billion of cost into the U.S. health care system , and comprises 3%[...]
The Cadex Genomics mission and passion is to improve the lives of cancer patients. They have developed a novel, blood-based assays for patients with cancer. Over the past several years they have been working diligently to bring their first product[...]
